Tag: iPSCs

Revolutionising neuromuscular disease research through 3D modelling Labmate Online

A recent case study published by AMSBIO highlights ground-breaking research in neuromuscular diseases. Led by Dr Roger Kamm at the Massachusetts Institute of Technology (MIT), this project focuses on developing a 3D microfluidic neuromuscular platform for modelling Motor Neuron Diseases (MNDs). MNDs, particularly amyotrophic lateral sclerosis (ALS), remain a significant…

Continue Reading Revolutionising neuromuscular disease research through 3D modelling Labmate Online

Neuromuscular disease research | Scientist Live

AMS Bio has published a case study that describes how a team of scientists, led by Dr. Roger Kamm from the Massachusetts Institute of Technology (MIT), has developed a protocol for the fabrication of a 3D microfluidic neuromuscular platform that can be used to model motor neurone diseases (MNDs). For one…

Continue Reading Neuromuscular disease research | Scientist Live

Wednesday Nite at the Lab – Isthmus

media release: WN@TL goes hybrid both with Zoom and with in-person (Room 1111) presentations. The zoom registration link is still go.wisc.edu/240r59. You can also watch a live web stream at on YouTube. On November 8 Su-Chun Zhang of Neuroscience  & of the Stem Cell and Regenerative Medicine Center will speak on…

Continue Reading Wednesday Nite at the Lab – Isthmus

Unveiling Fascinating Schizophrenia Discoveries: Brain Organoids, Genes, and Revolutionary Insights

Researchers have utilized advanced technology to gain insights into the neurodevelopmental origins of schizophrenia, a severe neuropsychiatric disease. In one study, scientists grew brain organoids derived from patients’ skin cells and discovered persistent axonal dysregulation in individuals with schizophrenia. In a separate study, researchers focused on a schizophrenia risk gene…

Continue Reading Unveiling Fascinating Schizophrenia Discoveries: Brain Organoids, Genes, and Revolutionary Insights

What is the main advantage of induced pluripotent stem cells iPSCs in

a) Gene therapy targets somatic cells, while knockout models target germline cells. b) Gene therapy targets germline cells, while knockout models target somatic cells. c) Gene therapy uses NHEJ, while knockout models use HDR. d) Gene therapy targets embryos, while knockout models target adult organisms. **Yamanaka Factors and Regenerative Medicine:**…

Continue Reading What is the main advantage of induced pluripotent stem cells iPSCs in

Novel Schizophrenia Insights from Brain Organoids and Genes

Summary: Researchers leveraged cutting-edge technology to gain insights into schizophrenia’s neurodevelopmental origins. The researchers grew brain organoids from patients’ skin cells, finding persistent axonal disruptions in those with schizophrenia. In another study, researchers zeroed in on a schizophrenia risk gene, CYFIP1, revealing its potential role in brain immune cells called…

Continue Reading Novel Schizophrenia Insights from Brain Organoids and Genes

What is protocol of iPSC differentiation to abT cell

The protocol for differentiating iPSCs into abT cells is not provided in the given information. The provided information does not mention the protocol for iPSC differentiation into abT cells. The protocol for iPSC differentiation to abT cells involves co-cultivation with OP9-DL1 stromal cells to induce the T-lymphoid program in multipotent…

Continue Reading What is protocol of iPSC differentiation to abT cell

Differentiated Stem Cells Can Kickstart Fertility in Mice

The ovaries normally produce eggs, but they lose this ability in some people, including those who have undergone chemotherapy. For many species, reproducing requires two key ingredients: an egg and sperm. But for some young and otherwise healthy people, eggs are nowhere to be found. This is known as premature…

Continue Reading Differentiated Stem Cells Can Kickstart Fertility in Mice

Human iPSCs for better human disease models

Abstract At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human-relevant disease models will expand scientific knowledge and de-risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells…

Continue Reading Human iPSCs for better human disease models

What is the methods of CAR-T differentiation from iPSC?

The paper proposes a triple-engineering strategy combining optimized CAR expression with cytolytic and persistence enhancements to overcome barriers in CAR-T differentiation from iPSCs. The method involves using EZH1-knockdown-mediated epigenetic reprogramming to generate iPSC-derived T cells, termed EZ-T cells, which can be transduced with CARs for enhanced antitumor activity. The paper…

Continue Reading What is the methods of CAR-T differentiation from iPSC?

FDA Grants Fast Track Designation to ANPD001, Autologous Investigational Cell Therapy for the Treatment of Parkinson’s Disease

SAN DIEGO, Oct. 19, 2023 /PRNewswire/ — Aspen Neuroscience today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for ANPD001 for the treatment of Parkinson’s disease (PD) to improve motor function. ANPD001, is a personalized (autologous) cell therapy under investigation to treat PD by…

Continue Reading FDA Grants Fast Track Designation to ANPD001, Autologous Investigational Cell Therapy for the Treatment of Parkinson’s Disease

What is the methods of delta gamma T differentiation from iPSC?

Gamma delta (gd) T cells can be differentiated from induced pluripotent stem cells (iPSCs) using various methods. One method involves induced culture of mononuclear cells containing IL-15, OKT-3, and IL-2 in a serum-free culture medium. This culture process leads to the induction of gd T cells. To promote the maturity…

Continue Reading What is the methods of delta gamma T differentiation from iPSC?

Bioreactor system announced | Scientist Live

The new Able 3D magnetic stir and disposable bioreactor system from AMS Bio provides cost-effective, lab-scale production of induced pluripotent stem (iPS) cell spheroid culture. Induced pluripotent stem cells grown in 3D spheroid suspension culture closely resemble embryoid body structures naturally formed by embryonic stem cells. Using an Able 3D bioreactor offers researchers…

Continue Reading Bioreactor system announced | Scientist Live

Scaling-up iPS spheroid culture production Labmate Online

AMSBIO introduces the ABLE 3D Magnetic Stir and Disposable Bioreactor System, a cost-effective solution for lab-scale induced pluripotent stem (iPS) cell spheroid culture production. Growing iPS cells in 3D spheroid suspension culture mimics the natural structure of embryoid bodies formed by embryonic stem cells. The ABLE 3D Bioreactor offers a…

Continue Reading Scaling-up iPS spheroid culture production Labmate Online

A Review of the Role of Bioreactors for iPSCs-Based Tissue-Engineered Articular Cartilage

A PubMed search was performed under the search terms (Osteoarthritis AND Treatment) OR (Bioreactor AND Cartilage) OR (Bioreactor AND Tissue Engineering) OR (Cartilage AND iPSCs) and a combination of those terms, with results limited to the English language and published in the last ten years. Other articles used in this…

Continue Reading A Review of the Role of Bioreactors for iPSCs-Based Tissue-Engineered Articular Cartilage

A Procedure for Directed Differentiation of Mature Kidney Podocytes from Stem Cells

Mature cells can be reprogrammed to regain their stem cell-like undifferentiated and proliferative state. These reprogrammed cells are called induced pluripotent stem cells or IPSCs. To differentiate pluripotent cells into podocytes-specialized cells involved in the filtration of waste from kidneys, begin by taking a suspension of human IPSCs in a…

Continue Reading A Procedure for Directed Differentiation of Mature Kidney Podocytes from Stem Cells

Flow electroporation technology

Sponsored Content by MaxCyte, Inc.Oct 19 2023Reviewed by Maria Osipova Oligonucleotide drugs are an emerging area of development that hold great promise for personalized treatment of rare diseases. There are approximately 8,000 distinct rare diseases, each individually affecting fewer than one in 2,000 people. Collectively, rare diseases impact more than…

Continue Reading Flow electroporation technology

Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast [2023-2030]

Global Induced Pluripotent Stem Cells (iPSCs) Market Outlook 2023-2030 – The Global Induced Pluripotent Stem Cells (iPSCs) Market research report 2023-2030 Adaptive Research Reports provides a detailed analysis. It covers different types (Human iPSCs , Mouse iPSCs ) and applications (Academic Research , Drug Development and Discovery , Toxicity Screening…

Continue Reading Global Induced Pluripotent Stem Cells (iPSCs) Market Forecast [2023-2030]

New model provides window into Alzheimer’s di

GRAND RAPIDS, Mich. (Oct. 18, 2023) — A new model developed by Van Andel Institute, Lund University and University of Florence scientists will enable researchers to better understand how Alzheimer’s disease progresses in the brain.   Like other neurodegenerative diseases, Alzheimer’s is challenging to study. It is immensely complex, develops…

Continue Reading New model provides window into Alzheimer’s di

Renowned ALS Researcher Confirms The Efficacy Of NeuroSense Therapeutics’ Lead Drug Candidate, PrimeC

HERZLIYA, ISRAEL / ACCESSWIRE / October 19, 2023 / Induced pluripotent stem cells (iPSCs) have emerged as a promising tool in the field of research and therapy for neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS). ALS is a progressive disorder that affects motor neurons, leading to muscle weakness, paralysis…

Continue Reading Renowned ALS Researcher Confirms The Efficacy Of NeuroSense Therapeutics’ Lead Drug Candidate, PrimeC

Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease

Cloning of CRISPR/sgRNA lentiviral constructs with fluorescent selection markers A tetracycline-inducible promoter (TRE3G) was used to control the expression of S. aureus dCas9 in a lentiviral vector. To facilitate selection of cells by FACS, pHR:TRE3G-SadCas9-2xKRAB-p2a-tdTomato (Addgene ID #209298) was subcloned from a pHR:TRE3G-SadCas9-2xKRAB-p2a-zeo (A gift from Professor Stanley Qi), where zeocin…

Continue Reading Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease

Renowned ALS Researcher Confirms The Efficacy Of NeuroSense Therapeutics’ Lead Drug Candidate, PrimeC – NeuroSense Therapeutics (NASDAQ:NRSN)

Induced pluripotent stem cells (iPSCs) have emerged as a promising tool in the field of research and therapy for neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS). ALS is a progressive disorder that affects motor neurons, leading to muscle weakness, paralysis and ultimately death. iPSCs are adult cells that have…

Continue Reading Renowned ALS Researcher Confirms The Efficacy Of NeuroSense Therapeutics’ Lead Drug Candidate, PrimeC – NeuroSense Therapeutics (NASDAQ:NRSN)

Neuron Navigator 1 (Nav1) regulates the response to cocaine in mice

Mouse strains All mouse procedures were approved by the Institutional Animal Care and Use Committees at Binghamton or Stanford University; and were conducted in accordance with the National Institute of Health Guide for Care and Use of Laboratory Animals, Eighth Edition. All mice were originally obtained from Jackson Laboratories, and…

Continue Reading Neuron Navigator 1 (Nav1) regulates the response to cocaine in mice

Delineating the dynamic transcriptional and epigenetic landscape regulating hematopoiesis

Credit: iScience (2023). DOI: 10.1016/j.isci.2023.107893 A research team led by Professor Megumu K. Saito (Department of Clinical Application) examined the dynamic transcriptional and epigenetic landscape during definitive hematopoiesis and revealed the non-redundant roles of ZEB2 and MEIS1 vital to producing hematopoietic stem cells from the hemogenic endothelium. The study is…

Continue Reading Delineating the dynamic transcriptional and epigenetic landscape regulating hematopoiesis

Human-derived proteins used in DREAM tool

CRISPR-DREAM tool used to activate insufficiently expressed genes and convert skin cells to induced pluripotent stem cells (iPSCs). Published in Nature Methods, Rice University bioengineers developed a tool that activates silent or insufficiently expressed genes using human-derived proteins termed mechanosensitive transcription factors. These naturally enable cells to switch on specific…

Continue Reading Human-derived proteins used in DREAM tool

Companies will use 3D brain model of Parkinson’s to find therapies

Stem Pharm and Verge Genomics are teaming up to develop a 3D brain model of Parkinson’s disease that uses advanced computational tools to validate new therapeutic candidates. The collaboration will leverage Stem Pharm’s human-derived “mini-brains” that model inflammation of the brain — neuroimmune organoids — and Verge’s expertise in human…

Continue Reading Companies will use 3D brain model of Parkinson’s to find therapies

Optimizing the Tet-On system for homogeneous iPSC myogenic differentiation

Credit: iScience (2023). DOI: 10.1016/j.isci.2023.107685 In a recent study published in iScience, researchers have optimized the Tet-On system to improve the efficiency of generating skeletal muscle cells and other differentiated cell types from iPSCs for various basic and clinical research purposes. The team was led by Associate Professor Hidetoshi Sakurai…

Continue Reading Optimizing the Tet-On system for homogeneous iPSC myogenic differentiation

DNA aptamer finds novel application in regulating cell differentiation

Generating specific cell lineages from induced pluripotent stem cells and embryonic stem cells is the holy grail of regenerative medicine. Guiding iPSCs toward a target cell line has garnered much attention, but the process remains challenging. Now, researchers from Japan have discovered that an anti-nucleolin DNA aptamer, iSN04, can determine…

Continue Reading DNA aptamer finds novel application in regulating cell differentiation

PrimeC boosts survival of motor neurons derived from ALS patients | Potential oral therapy in Phase 2b trial with results likely this year

PrimeC, NeuroSense Therapeutics‘ investigational, fixed-dose combination therapy for amyotrophic lateral sclerosis (ALS), significantly boosted the survival of patient-derived motor neurons to levels similar to healthy controls in a lab study. The independent study was led by Justin Ichida, PhD, a professor of stem cell biology and regenerative medicine at the…

Continue Reading PrimeC boosts survival of motor neurons derived from ALS patients | Potential oral therapy in Phase 2b trial with results likely this year

BU researcher receives funds for AATD researc

(Boston)—Andrew A. Wilson, MD, associate professor of medicine at Boston University Chobanian & Avedisian School of Medicine, recently received a gift of $100,000 to establish the Katharine Howe Lovett Fund for Alpha-1 antitrypsin deficiency (AATD) Research. The funds were a gift from Philip Lovett and Beatrice Liu, given in memory…

Continue Reading BU researcher receives funds for AATD researc

Sygnature, Axol Partner On IPSC-Derived Microglial Cells

Sygnature Discovery, an integrated drug discovery provider, is joining forces with Axol Bioscience, a company involved in scientific collaboration with human induced pluripotent stem cell (iPSC), to explore the incorporation of human iPSC-derived microglia into high-content imaging in vitroscreening workflows. Human iPSC-derived cells are stem cells derived from patient donors…

Continue Reading Sygnature, Axol Partner On IPSC-Derived Microglial Cells

A versatile tool for regenerative medicine and beyond

Generating specific cell lineages from induced pluripotent stem cells and embryonic stem cells is the holy grail of regenerative medicine. Guiding iPSCs toward a target cell line has garnered much attention, but the process remains challenging. Now, researchers from Japan have discovered that an anti-nucleolin DNA aptamer, iSN04, can determine…

Continue Reading A versatile tool for regenerative medicine and beyond

NeuroSense’s PrimeC Shows Compelling Results for ALS Survival in Novel iPSC Model

Key Points: Groundbreaking study utilized iPSCs derived from blood samples of ALS patients to evaluate the survival rate of induced motor neurons when treated with NeuroSense’s product candidate, PrimeC. In collaboration with the University of Southern California’s Ichida Stem Cell Lab, PrimeC significantly increased the survival rate of induced motor…

Continue Reading NeuroSense’s PrimeC Shows Compelling Results for ALS Survival in Novel iPSC Model

Creating an iPS cell resource for rare and intractable diseases

Basic characterization of established iPSCs. A Representative phase contrast images of iPSC colonies. iPSC clones from the patients with (i) Duchenne muscular dystrophy, (ii) Alexander disease, (iii) Dravet syndrome and (iv) Smith-Magenis syndrome are shown. Scale bars = 100 μm. B Estimation of the cell type from which iPSCs originated; n = 1,532. C…

Continue Reading Creating an iPS cell resource for rare and intractable diseases

Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A

. 2023 Oct 4:bloodadvances.2023010838. doi: 10.1182/bloodadvances.2023010838. Online ahead of print. Affiliations Expand Affiliations 1 Jichi Medical University, Tochigi, Japan. 2 Tokyo Medical University, Tokyo, Japan. 3 Jichi Medical University, Simotsuke, Tochigi, Japan. 4 The University of Tokyo, Tokyo, Japan. Item in Clipboard Takafumi Hiramoto et al. Blood Adv. 2023. Show details…

Continue Reading Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia A

The Engineer – 3D printed stem cells could help repair brain injuries

Oxford University researchers have used human stem cells to 3D print tissue that mimics the cerebral cortex and shows promise for treating brain injuries. Described in Nature Communications, the work ultimately saw the Oxford team implanting the 3D printed structures into mouse brain slices. According to the researchers, the…

Continue Reading The Engineer – 3D printed stem cells could help repair brain injuries

Scientists develop 3D printing method that shows promise for repairing brain injuries

Researchers have produced an engineered tissue representing a simplified cerebral cortex by 3D printing human stem cells. When implanted into mouse brain slices, the structures became integrated with the host tissue. The breakthrough technique developed by University of Oxford researchers could one day provide tailored repairs for those who suffer…

Continue Reading Scientists develop 3D printing method that shows promise for repairing brain injuries

Revolutionary 3D-Printing Technique Uses Stem Cells To Repair Brain Injuries

OXFORD, United Kingdom — Scientists from the University of Oxford have developed an innovative 3D-printing technique that might one day revolutionize treatments for brain injuries. This technique involves creating neural cells that emulate the structure of the cerebral cortex, the brain’s outer layer. Brain injuries, resulting from trauma, strokes, or…

Continue Reading Revolutionary 3D-Printing Technique Uses Stem Cells To Repair Brain Injuries

2023 Axol Bioscience eBook | AXOL Bioscience

Learn about our ongoing work with human iPSCs     There is a clear and increasingly urgent need for better human disease models in drug discovery. Thankfully, the industry is becoming increasingly aware of the pivotal role human iPSCs will play in physiologically-relevant in vitro models to develop better, safer therapies….

Continue Reading 2023 Axol Bioscience eBook | AXOL Bioscience

2023 Induced Pluripotent Stem Cells Production Market| North America is expected to have the Significant Market Share over the Forecast Period

PRESS RELEASE Published October 4, 2023 The Global Induced Pluripotent Stem Cells Production Market Analysis to 2030 is a specialized and in-depth study of the technology, media and telecommunication industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Induced…

Continue Reading 2023 Induced Pluripotent Stem Cells Production Market| North America is expected to have the Significant Market Share over the Forecast Period

REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs

Gameto plans to use the iPSC line to advance its program, Fertilo, designed to improve IVF and egg freezing. NEW YORK, Oct. 4, 2023 /PRNewswire/ — REPROCELL Inc. today announced that it has entered into an agreement to grant Gameto Inc., a female-led biotechnology company with a mission to redefine…

Continue Reading REPROCELL Announces License Agreement with Gameto for the Advancement of its Program to Improve Assisted Fertility using iPSCs

NeuroSense’s PrimeC Demonstrates Outstanding Effect on ALS Survival in Innovative iPSC Model

In collaboration with the University of Southern California’s Ichida Stem Cell Lab, PrimeC was shown to significantly increase survival rate of induced motor neurons in an in vitro study utilizing induced pluripotent stem cells (iPSCs) generated from people living with ALS Results reinforce previous findings in multiple models  In a previous…

Continue Reading NeuroSense’s PrimeC Demonstrates Outstanding Effect on ALS Survival in Innovative iPSC Model

Microglial states and their impact on Alzheimer’s disease

In a recent study published in Cell, researchers examined 152,459 microglial transcriptomes from 443 individuals, identifying 12 transcriptional states and their relationship to Alzheimer’s disease (AD). Study: Human microglial state dynamics in Alzheimer’s disease progression. Image Credit: Nefedova Tanya/Shutterstock.com Background Microglia play crucial roles in brain cells, changing states to…

Continue Reading Microglial states and their impact on Alzheimer’s disease

Precise genome editing human stem cells for functional interrogation of genetic variation

Abstract Human induced pluripotent stem cells (iPSCs) provide great potential as a tool for basic biological discovery, disease modeling, and ultimately for cell based regenerative medicine but the full realization of these stem cells requires an ability to precisely edit their genome in an efficient way. The relative efficiencies of…

Continue Reading Precise genome editing human stem cells for functional interrogation of genetic variation

Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells

Background: In vitro production of hematopoietic stem/progenitor cells (HSPCs) from human-induced pluripotent stem cells (hiPSCs) provides opportunities for fundamental research, disease modeling, and large-scale production of HLA-matched HSPCs for therapeutic applications. However, a comprehensive understanding of the signaling mechanisms that regulate human hematopoiesis is needed to develop a more effective…

Continue Reading Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells

Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells | Stem Cell Research & Therapy

Culture of human-induced pluripotent stem cells (hiPSCs) Human iPSC lines were cultured in Matrigel-coated plates in the Nutristem medium (Corning, USA). Cells were passaged every 5 days by treating with Versene (Thermo Fisher Scientific, USA) for 3–5 min, transferred to freshly prepared Matrigel-coated plates, and cultured under hypoxic conditions with 5% CO2…

Continue Reading Role of YAP in hematopoietic differentiation and erythroid lineage specification of human-induced pluripotent stem cells | Stem Cell Research & Therapy

Alginate Beads as a Tool for Production of Human IPSCs

Introduction There are several promising applications for human-induced pluripotent stem cells (IPSCs), including cell replacement therapies, tissue engineering, and high-throughput toxicological and pharmacological screening.1 The scalable expansion and differentiation of IPSCs are demanding and inefficient; in particular, they commonly require the use of two-dimensional (2D) cultures.2 Data on stem cell…

Continue Reading Alginate Beads as a Tool for Production of Human IPSCs

Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer

CELL-EASY Gisele Deblandre, Cell-Easy’s Chief Scientific Officer We’re thrilled to welcome Gisele Deblandre as our new Chief Scientific Officer! TOULOUSE, France, Sept. 28, 2023 (GLOBE NEWSWIRE) — Cell-Easy, a specialized contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre as the Chief…

Continue Reading Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer

Medical Venture’s iPSC-Based Heart Failure Treatment Breaks New Ground

In a groundbreaking clinical trial, two patients suffering from severe heart failure experienced improvements in their symptoms through an innovative procedure. The clinical trial was conducted by Heartseed, a medical venture associated with Keio University in Tokyo’s Shinjuku Ward.  The procedure involves the transplantation of “cardiomyocyte spheroids” (CM spheroids), spherical…

Continue Reading Medical Venture’s iPSC-Based Heart Failure Treatment Breaks New Ground

iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy

Induced pluripotent stem cells (iPSCs), obtained by reprogramming different somatic cell types, represent a promising tool for the study of drug toxicities, especially in the context of personalized medicine. Indeed, these cells retain the same genetic heritage of the donor, allowing the development of personalized models. In addition, they represent…

Continue Reading iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy

Stem Cell Therapy Market to Set Stunning Growth From 2023 to 2031

PRESS RELEASE Published September 27, 2023 [125 Report Pages] Stem Cell Therapy Market Analysis 2023 | by Product Type (, Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs), Very Small Embryonic Like Stem Cells), Application Type (, Regenerative Medicine, Drug Discovery and Development), Business…

Continue Reading Stem Cell Therapy Market to Set Stunning Growth From 2023 to 2031

GB116 QB Development.pdf – 1. iPSCs induced pluripotent stem cells are created by causing a mature body cell to revert to the developmental state

1.iPSCs, induced pluripotent stem cells,are created by causing a mature bodycell to revert to the developmentalstate found in a mature ___. a.Blastocyst b.Gastrula c.Neurula d.None of the above. Pluripotent cells are only found in the two-blastomere stage ofdevelopment e.None of the above. Pluripotent are not seen until the end of…

Continue Reading GB116 QB Development.pdf – 1. iPSCs induced pluripotent stem cells are created by causing a mature body cell to revert to the developmental state

Solved A PhD student leaving for vacation has asked an

A PhD student leaving for vacation has asked an undergraduate student to perform daily media changesfor his iPSCs while he is gone. The culture is happening in 12-well plates where a volume of 2 mL is optimal.On Saturday, when changing the media, the undergraduate decides to add 4 ml of…

Continue Reading Solved A PhD student leaving for vacation has asked an

Early Toxicity Testing Market Growth, Business Overview, Forecast 2023 to 2030

PRESS RELEASE Published September 26, 2023 Detailed analysis of the report “Early Toxicity Testing Market” helps to understand the various types of Early Toxicity Testing products that are currently in use, along with the variants that would gain prominence in the future by Infinitybusinessinsights.com. This report will help the viewer…

Continue Reading Early Toxicity Testing Market Growth, Business Overview, Forecast 2023 to 2030

Blood, the new red gold of regenerative medicine? -Kaya Alana

0 Regenerative medicine has perhaps found the necessary vein for it to finally be complete and viable in the long term. A vein of red gold that could revolutionize the medicine of tomorrow. For those who are wondering what regenerative medicine and “red gold” are, I will come to that…

Continue Reading Blood, the new red gold of regenerative medicine? -Kaya Alana

CytoMed Therapeutics Granted Patent for iPSCBased Technology Paving the Way for Revolutionary Cancer Treatments

On September 25, 2023, CytoMed Therapeutics, a spinoff of ASTAR, made an exciting announcement. Their exclusively licensed induced pluripotent stem cell (iPSC)-based technology has been granted a patent by the China National Intellectual Property Administration. This groundbreaking patent holds immense significance, as iPSCs are a remarkable type of stem cell…

Continue Reading CytoMed Therapeutics Granted Patent for iPSCBased Technology Paving the Way for Revolutionary Cancer Treatments

Induced Pluripotent Stem Cells (iPSCs) and Genetic Engineering

Benabdellah, K., Sánchez-Hernández, S., Aguilar-González, A., Maldonado-Pérez, N., Gutierrez-Guerrero, A., Cortijo-Gutierrez, M., Ramos-Hernández, I., Tristán-Manzano, M., Galindo-Moreno, P., Herrera, C., & Martin, F. (2020). Genome-edited adult stem cells: Next-generation advanced therapy medicinal products. Stem Cells Translational Medicine, 9(6), 674–685. doi.org/10.1002/sctm.19-0338 Chang, C. W., Lai, Y. S., Pawlik, K. M., Liu,…

Continue Reading Induced Pluripotent Stem Cells (iPSCs) and Genetic Engineering

Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection

Title:Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection Volume: 10 Issue: 3 Author(s): Lin Cheng, Yong Zhang, Yuemin Nan and Liang Qiao Affiliation: Keywords: Disease modeling, hepatitis C virus, hepatocellular carcinoma, induced pluripotent stem cells, iPSCs, liver transplantation. Abstract: The development of induced pluripotent stem…

Continue Reading Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection

Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations | Journal of Biomedical Science

Wallace DC. Mitochondrial genetic medicine. Nat Genet. 2018;50:1642–9. Article  CAS  PubMed  Google Scholar  Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145–59. Article  CAS  PubMed  PubMed Central  Google Scholar  Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006;125(7):1241–52. Article  CAS  PubMed  Google Scholar  Picard…

Continue Reading Induced pluripotent stem cells: ex vivo models for human diseases due to mitochondrial DNA mutations | Journal of Biomedical Science

Global Induced Pluripotent Stem Cells (iPSCs) Market Share [2023-2030]

Global Induced Pluripotent Stem Cells (iPSCs) Market Overview [2023] – Global “Induced Pluripotent Stem Cells (iPSCs) Market” (2023-2030) research report gives the most upcoming industry information on the real market situation and future outlook. This report provides you analysis of the Induced Pluripotent Stem Cells (iPSCs) market size, share, future…

Continue Reading Global Induced Pluripotent Stem Cells (iPSCs) Market Share [2023-2030]

DNA Polymerases Market is Projected to Grow at a Steady CAGR of 6.2%, Reaching a Valuation of US$ 647.5 Million by 2033

The United States is likely to hold the lead in the global DNA polymerase market through the assessment period. NEWARK, DELAWARE, UNITED STATES OF AMERICA, September 22, 2023/EINPresswire.com/ — As per Future Market Insights, the DNA Polymerase Market is anticipated to expand, with a total worth expected to exceed US$…

Continue Reading DNA Polymerases Market is Projected to Grow at a Steady CAGR of 6.2%, Reaching a Valuation of US$ 647.5 Million by 2033

Stem Cell Hair Transplant Treatment Market Rise in Share, Size 2023 Trends with Key Players

PRESS RELEASE Published September 22, 2023 The report provides a comprehensive analysis of The Stem Cell Hair Transplant Treatment Market, covering various aspects such as market size, market status, market trends, and forecast. The report also highlights the key market drivers, growth opportunities, and competitive landscape. The market size and…

Continue Reading Stem Cell Hair Transplant Treatment Market Rise in Share, Size 2023 Trends with Key Players

Stem Cells and Regenerative Medicine: A Journey into Quality and Consistency

Key Takeaways: Induced pluripotent stem cells (iPSCs) are the future of regenerative medicine, but quality and consistency are paramount mRNA-based reprogramming offers higher efficiency and safety for iPSC generation than DNA-based reprogramming Ensuring consistent quality in iPSC-derived cell therapy requires a comprehensive approach that includes core technology, GMP compliance, good…

Continue Reading Stem Cells and Regenerative Medicine: A Journey into Quality and Consistency

precoated microcarriers for iPSCs culture

The Non-animal Alternative Testing Market is Projected to Reach over ✨$4.5 Billion✨ by 2032 It was valued at $1.7 billion in 2022. That is a compound annual growth rate of 10.3%. New technologies offering non-animal testing alternatives are constantly emerging: Cell culture systems, hydrogels, computer modeling and organs-on-chip… These technologies…

Continue Reading precoated microcarriers for iPSCs culture

Deepening the role of excitation/inhibition balance in human iPSCs-derived neuronal networks coupled to MEAs during long-term development

In the brain of healthy subjects, the neuronal activity is kept and controlled by a precise and well-defined balance between excitation (E) and inhibition (I) (Mossink et al 2022), defined as ‘E/I balance’. Since GABA is the main inhibitory neurotransmitter of the central nervous system (Leinekugel et al 1999), it…

Continue Reading Deepening the role of excitation/inhibition balance in human iPSCs-derived neuronal networks coupled to MEAs during long-term development

Century Therapeutics, Inc. (NASDAQ: IPSC) Reports Decrease in Short Interest and Mixed Analyst Ratings

Century Therapeutics, Inc. (NASDAQ: IPSC) experienced a significant decrease in its short interest during the month of August, according to recent data. As of August 31st, the total number of shares on short interest was 642,200, marking a decline of 14.0% from the previous total of 747,100 shares on August…

Continue Reading Century Therapeutics, Inc. (NASDAQ: IPSC) Reports Decrease in Short Interest and Mixed Analyst Ratings

Brain microvascular endothelial cells and blood-brain barrier dysfunction in psychotic disorders

Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223. Article  PubMed  Google Scholar  Martin J, Taylor MJ, Lichtenstein P….

Continue Reading Brain microvascular endothelial cells and blood-brain barrier dysfunction in psychotic disorders

Typical reductionist approach – iPSCs in disease modelling 1) finding out how much a particular

iPSCs in disease modelling 1) finding out how much a particular variant/mutation contributes to the phenotype (correcting or inducing genetic polymorphisms) 2) alternatively, using reporter genes to discover which genes are essential for cell differentiation, and in knockout mouse models, how cell differentiation is different/impacted (e.g. dopaminergic neuron development in…

Continue Reading Typical reductionist approach – iPSCs in disease modelling 1) finding out how much a particular

Shoreline Smashes Fate Thx and Whitehead in Legal Battle Over iPSCs

Shoreline Biosciences Wins a Comprehensive Summary Judgment Victory on All Claims Brought by Fate Therapeutics and Whitehead Institute on iPSC Generation and Use September 7, 2023, SAN DIEGO – Shoreline Biosciences, Inc., a biopharmaceutical company developing effective and differentiated cellular immunotherapies based on induced pluripotent stem cells (iPSCs) derived natural…

Continue Reading Shoreline Smashes Fate Thx and Whitehead in Legal Battle Over iPSCs

The Rise of Human iPSC Banks as a Means of Making iPS Cells Widely Available

The high cost of producing and validating induced pluripotent stem cells (iPSCs or iPS cells) makes them inaccessible for many researchers. This has necessitated the creation of cell banks that can provide high-quality iPSCs to researchers who would otherwise be unable to produce and characterize these cells within their own…

Continue Reading The Rise of Human iPSC Banks as a Means of Making iPS Cells Widely Available

iPSCs are Transforming Drug Discovery, Toxicity Testing, Disease Modeling, and Beyond

Induced pluripotent stem cells (iPS cells or iPSCs) are laboratory-made pluripotent stem cells that are produced using adult cells. They are derived from somatic cells by reprogramming artificially and turning on the expression of specific pluripotency genes. The reprogramming is achieved using different techniques with varying efficiencies. The iPSC technology…

Continue Reading iPSCs are Transforming Drug Discovery, Toxicity Testing, Disease Modeling, and Beyond

Induced Pluripotent Stem Cells (iPSCs) Market | New Invention and Future Demand Dynamics By 2030

A recent study report named “Induced Pluripotent Stem Cells (iPSCs) Market” provides a comprehensive analysis of the market’s development potential, income generating potential, and present trends. The report includes comprehensive segmentation data by type [ , Human iPSCs , Mouse iPSCs , Human iPSCs had a market share of 89.65percent…

Continue Reading Induced Pluripotent Stem Cells (iPSCs) Market | New Invention and Future Demand Dynamics By 2030

Perturbations of Glutathione and Sphingosine Metabolites in Port Wine Birthmark Patient-Derived Induced Pluripotent Stem Cells

Abstract Port Wine Birthmarks (PWBs) are a congenital vascular malformation on the skin, occurring in 1–3 per 1000 live births. We have recently generated PWB-derived induced pluripotent stem cells (iPSCs) as clinically relevant disease models. The metabolites associated with the pathological phenotypes of PWB-derived iPSCs are unknown, and so we…

Continue Reading Perturbations of Glutathione and Sphingosine Metabolites in Port Wine Birthmark Patient-Derived Induced Pluripotent Stem Cells

Heart Cells in Space Help Advance Treatments for Cardiovascular Disease

KENNEDY SPACE CENTER (FL), September 12, 2023 – Heart disease is the leading cause of death globally, and once cardiovascular tissue is damaged, there’s no means of restoring its function. But it’s possible damaged tissue could be regenerated via stem cell therapies. To that end, a team of scientists took…

Continue Reading Heart Cells in Space Help Advance Treatments for Cardiovascular Disease

Induced Pluripotent Stem Cells (iPSCs) Market Trends Report 2023-2030 | 91 Pages Report

[91 Pages Report] “Induced Pluripotent Stem Cells (iPSCs) Market” Market Size, Share and Industry Trends Analysis Report By Applications (Academic Research, Drug Development and Discovery, Toxicity Screening, Regenerative Medicine, Others),Types (Human iPSCs, Mouse iPSCs), By Regional Outlook and Forecast, 2023-2030. The report presents the research and analysis provided within the…

Continue Reading Induced Pluripotent Stem Cells (iPSCs) Market Trends Report 2023-2030 | 91 Pages Report

Induced Pluripotent Stem Cells (iPSCs) Market Overview 2023 with Stastical data and Forecast till 2030

“Induced Pluripotent Stem Cells (iPSCs) Market” Size, Share, Growth Report 2023-2030 | | No. of pages: 109Report which offers an in-depth analysis Grounded on Applications (Manufacturing, Academic Research, Drug Development And Discover, Toxicity Screening, Regenerative Medicine), and Types (Hepatocytes, Fibroblasts, Amniotic Cells, Cardiomyocytes, Others) and expected to grow annually by…

Continue Reading Induced Pluripotent Stem Cells (iPSCs) Market Overview 2023 with Stastical data and Forecast till 2030

iPSC Technology Grows Even More Powerful and Disruptive

Since the discovery and development of induced pluripotent stem cell (iPSC or iPS cell) technology a decade ago, significant progress has been made within stem cell biology and regenerative medicine. In recent years, iPSCs have been used extensively in disease modeling, drug discovery, and cell therapy applications. Importantly, new pathological…

Continue Reading iPSC Technology Grows Even More Powerful and Disruptive

Knighted in 2008, Sir Ian Wilmut revolutionized the field of cloning, stem cell research, and regenerative medicine.

Ian Wilmut, the embryologist most known for cloning Dolly the sheep, passed away at age 79 from complications of Parkinson’s Disease, according to news from the University of Edinburgh. Wilmut’s work represented a milestone in the field of regenerative medicine and stem cell research. Born to teachers in a Warwickshire…

Continue Reading Knighted in 2008, Sir Ian Wilmut revolutionized the field of cloning, stem cell research, and regenerative medicine.

Comparison of miRNA transcriptome of exosomes in three categories of somatic cells with derived iPSCs

doi: 10.1038/s41597-023-02493-5. Chunlai Yu #  1 , Mei Zhang #  2 , Yucui Xiong  3 , Qizheng Wang  3 , Yuanhua Wang  3 , Shaoling Wu  4 , Sajjad Hussain  3   5 , Yan Wang  3 , Zhizhong Zhang  3 , Nini Rao  6 , Sheng Zhang  7 , Xiao Zhang  8   9 Affiliations Expand Affiliations 1 University of Electronic Science…

Continue Reading Comparison of miRNA transcriptome of exosomes in three categories of somatic cells with derived iPSCs

Scientists grow human kidneys in pig embryos

GUANGZHOU — A Chinese team has grown, for the first time in the world, early kidneys from human stem cells inside pig embryos. The advance that brings pig-grown human organs closer to reality will open an exciting avenue for kidney transplants and a new window for studying human kidney development,…

Continue Reading Scientists grow human kidneys in pig embryos

Century Therapeutics, Inc. Receives “Moderate Buy” Rating from Analysts

Century Therapeutics, Inc. (NASDAQ: IPSC) has been given an average rating of “Moderate Buy” by eight ratings firms that are covering the company, according to a report by MarketBeat Ratings. Of the eight firms, one equities research analyst has rated the stock with a hold rating, while seven have issued…

Continue Reading Century Therapeutics, Inc. Receives “Moderate Buy” Rating from Analysts

Allogeneic iPSCs Gaining Momentum Due to Ease of Access and Economies of Scale

While autologous iPSC-based cell therapies are patient-specific, allogeneic iPSC-based cell therapies use donor-derived cells as a starting material. In recent years, a greater number of allogeneic iPSC-derived cell therapies are being studied than autologous therapies. One of the advantages of allogeneic therapy is that a large number of doses can…

Continue Reading Allogeneic iPSCs Gaining Momentum Due to Ease of Access and Economies of Scale

Gene-Edited iPSCs | Creative Bioarray

In recent years, the application of CRISPR-mediated gene editing in iPS cells has attracted more and more attention. It has great potential application value in the establishment of disease models and mechanism research, cell therapy, drug discovery and evaluation. With over a decade of experience in the iPSC field, we…

Continue Reading Gene-Edited iPSCs | Creative Bioarray

A disease-specific iPS cell resource for studying rare and intractable diseases | Inflammation and Regeneration

We thank the patients and their families for their cooperation in this study. We are grateful to Ms. Suga Hasegawa (CiRA, Kyoto University, Kyoto, Japan), Ms. Ayumi Matsunaga (iPS Cell Research Foundation, Kyoto, Japan), and Ms. Harumi Watanabe (CiRA, Kyoto University, Kyoto, Japan) for their administrative assistance. We also thank…

Continue Reading A disease-specific iPS cell resource for studying rare and intractable diseases | Inflammation and Regeneration

Cell Therapy Technologies Market booms as life-saving innovations reach new milestones

The cell therapy technologies market is projected to reach 8.0 Billion by 2027 from USD 4.0 Billion in 2022, at a CAGR of 14.6% during the forecast period. The global cell therapy technologies market is projected to reach USD 8.0 billion by 2027 from USD 4.0 billion in 2022, at…

Continue Reading Cell Therapy Technologies Market booms as life-saving innovations reach new milestones

Engineered stem cells could regenerate PF-damaged tissue: Studies

Scientists have developed a way to use engineered specialized stem cells to regenerate healthy airway tissues, offering a potential avenue for treating chronic lung diseases like pulmonary fibrosis (PF). In a pair of proof-of-concept preclinical studies published in Cell Stem Cell, scientists described how they engineered lung stem cells and…

Continue Reading Engineered stem cells could regenerate PF-damaged tissue: Studies

17 Captivating Facts About Induced Pluripotent Stem Cells (Ipscs)

iPSCs are a revolutionary breakthrough in regenerative medicine. Induced pluripotent stem cells (iPSCs) are a type of stem cell that has the remarkable ability to differentiate into many different cell types in the body. This has opened up new possibilities in regenerative medicine for treating various diseases and injuries. They…

Continue Reading 17 Captivating Facts About Induced Pluripotent Stem Cells (Ipscs)

Synthego and bit.bio join forces on genetic engineering platform

Genome engineering company Synthego has partnered with synthetic biology company bit.bio to build a platform that will implement synthetic circuitry in cells for therapeutic applications. The goal of the project is to advance the field of genetic engineering for cell therapies, making them safer, more efficient, and more accessible to…

Continue Reading Synthego and bit.bio join forces on genetic engineering platform

Humanized Kidney Development Described In Chimeric Pig Embryos

Kidney illustration getty In a bid to improve organ transplant options in the future, a team led by researchers at the Chinese Academy of Sciences has shown that it’s possible to produce pig embryos containing “humanized” pre-kidney structures. To do so, the researchers turned to a chimeric embryo approach, introducing…

Continue Reading Humanized Kidney Development Described In Chimeric Pig Embryos

iPSCs Manufacturing Services Market Know the Scope and Trends and Detailed Study Analysis

InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled Global iPSCs Manufacturing Services Market (By Application (Research Products, Drug Development & Discovery, Cellular Therapy, Toxicology Screening, Personalized Medicine, Disease Modelling, Stem Cell Banking, Emerging Applications), End-User(Pharmaceutical & Biotechnology Companies, Academic institutes, Research Laboratories & CROs,…

Continue Reading iPSCs Manufacturing Services Market Know the Scope and Trends and Detailed Study Analysis

Distribution Agreement Brings Single-Cell Handling Solutions to China Labmate Online

iotaSciences, a pioneer in the single-cell handling solutions field, and Quantum Design China, a subsidiary of Quantum Design International, have announced an exclusive distribution partnership for iotaSciences’ proprietary single-cell handling platforms in China. Lambert Cao, General Manager of Quantum Design China, expressed excitement about offering Chinese customers access to iotaSciences’…

Continue Reading Distribution Agreement Brings Single-Cell Handling Solutions to China Labmate Online

Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics

Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ: ERNA). “We have generated what we believe to be unprecedented data in the setting of dry age-related macular…

Continue Reading Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics

Lineage Initiates Development Activities Under Licensing Agreement with Eterna

Lineage Cell Therapeutics Inc has begun development activities to create a novel hypoimmune induced pluripotent stem cell (iPSC) line as part of its collaboration with Eterna Therapeutics Inc. This collaboration aims to explore new areas of technology, including gene editing, hypo immunity, and iPSCs. The companies are focused on developing…

Continue Reading Lineage Initiates Development Activities Under Licensing Agreement with Eterna

iPSCs Manufacturing Services Market Size, Share and Growth Factors Study

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the Global iPSCs Manufacturing Services Market by (Applications (Research Products, Drug Development & Discovery, Cellular Therapy, Toxicology Screening, Personalized Medicine, Disease Modelling, Stem Cell Banking, and Emerging Applications), End-user (Pharmaceutical & Biotechnology Companies, Academic institutes, Research Laboratories…

Continue Reading iPSCs Manufacturing Services Market Size, Share and Growth Factors Study

Clock.bio launches to decode rejuvenation biology across human genome

Biotech on $4m mission to extend healthspan by 20 years based on biomarkers of aging in Phase 3 trial by the end of this decade. Clock.bio, a longevity biotech developing novel regenerative medicines leveraging the natural ability of human pluripotent stem cells to prevent and treat age-related diseases, today announced…

Continue Reading Clock.bio launches to decode rejuvenation biology across human genome

New Method Discovered to Fully Reprogram Stem Cells

Scientists have developed a new method of reprogramming cells to be better suited for use as stem cells. Induced pluripotent stem cells (iPSCs) have been used in medical research since 2006, allowing scientists to model diseases and develop therapies. However, iPSCs still retain some genetic reminders of their previous state…

Continue Reading New Method Discovered to Fully Reprogram Stem Cells

For the first time, scientists have completely erased a cell’s memory before turning it into a stem cell

Scientists have already found their way to transform human cells into new shapes, using a special mixture of chemicals to nudge humble skin cells into resilient tissues known as induced pluripotent stem cells. Despite this new lease on life, these specific cells still retain some genetic reminders of their time…

Continue Reading For the first time, scientists have completely erased a cell’s memory before turning it into a stem cell

In a First, Scientists Fully Wipe a Cell’s Memory Before Turning It Into a Stem Cell : ScienceAlert

Scientists already have their ways of coaxing human cells into new forms, using a special concoction of chemicals to nudge humble skin cells into malleable tissues known as induced pluripotent stem cells. In spite of this new lease on life, these particular cells still retain a few genetic reminders of…

Continue Reading In a First, Scientists Fully Wipe a Cell’s Memory Before Turning It Into a Stem Cell : ScienceAlert

Drug Discovery Article Competition Winner

We are thrilled to announce the winner of the Drug Target Review x ELRIG’s Article Competition: Dr Rosa Woldegebriel, Lead Scientist at the Human Centric Drug Discovery in Oxford, UK, whose article titled “Advancing Drug Discovery for Pain Disorders: Human iPSC-Based Approach” presents a revolutionary method in pharmaceutical research. Addressing…

Continue Reading Drug Discovery Article Competition Winner

Using iPSC-derived cortical organoids to study disease mechanisms of POLG-disease and explore new therapeutic strategies

Sammendrag POLG-related diseases are a set of severe mitochondrial myopathies caused by a mutation in the POLG gene. The POLG gene encodes for the catalytic subunit of the mitochondrial DNA (mtDNA) polymerase gamma (Pol-γ). Pol-γ is responsible for the replication and maintenance of mtDNA, and dysfunction of Pol-γ due to…

Continue Reading Using iPSC-derived cortical organoids to study disease mechanisms of POLG-disease and explore new therapeutic strategies